Crime involving counterfeit or substandard versions of FDA-regulated products, including pharmaceutical crime, is a profitable business. Transnational organized crime groups have proven quick to adapt to new opportunities and can be resilient in the face of traditional law enforcement measures.
OCI pursues offenders who violate the Food, Drug & Cosmetics Act (FDCA) from outside the U.S. if their crimes involve an FDA-regulated product intended for import into the United States.
OCI continues to expand its international outreach, with special agents permanently assigned to both Europol headquarters in The Hague, The Netherlands, and at Interpol’s Global Complex for Innovation, located in Singapore.
OCI agents also work closely with their law enforcement partners through leadership of the Permanent Forum on International Pharmaceutical Crime (www.pfipc.org). (1)
Beyond its international criminal investigations and liaison, OCI is a world leader in public-health law enforcement and often shares its knowledge, expertise and experience with other countries in areas, focusing on areas such as cybercrime, transnational pharmaceutical trafficking, and fraud.
This leadership enables OCI to act nimbly in the face of criminals who know no borders and ignore laws and the public’s health.